arrow
W

William C. Chang

walter reed army institute of research
H指数:18
被引数:1,083

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Production of Clinical-Grade SARS-CoV-2 Spike Ferritin Nanoparticle Protein Immunogen by Transient Transfection

通过瞬时转染生产临床级SARS-CoV-2 Spike Ferritin Nanoparticle Protein免疫原

2026-03-030
OAAI
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques
2024-01-033
OAAI
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity
2023-07-2712
OAAI
Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques
2023-04-014
OAAI
SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ induces long-lived plasma cells and cross-neutralizing antibodies
2023-03-1812
OAAI
Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity
2023-02-0316
OAAI
Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFN
2022-11-234
OAAI
A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine Is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) Model
2022-05-0420
OAAI
A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates
2022-02-1694
OA
SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses
2021-12-1356
OAAI
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
2021-12-01114
OAAI
Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations
2021-10-2942
OAAI
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques
2021-09-0143
OAAI